￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Reimbursement Policy for Sparsentan/Sparsentan

2026-02-01 22:25:32

Check Details
None

2026-02-01 22:25:32

Check Details
Ohtuvayre (Ensifentrine) - Can Ensifentrine Cure COPD?

2026-02-01 22:25:32

Check Details
Ohtuvayre (Ensifentrine) – How long should Ensifentrine be used?

2026-02-01 22:25:32

Check Details
Ohtuvayre (Ensifentrine) - Is Ensifentrine a targeted drug?

2026-02-01 22:25:32

Check Details
Ohtuvayre (Ensifentrine) - Is there a generic version of Ensifentrine?

2026-02-01 22:25:32

Check Details
Is there imported original research Ohtuvayre (Ensifentrine)-Ensifentine in China?

2026-02-01 22:25:32

Check Details
Ohtuvayre (Ensifentrine)-Ensifentrine specifications and dosage forms

2026-02-01 22:25:32

Check Details
Do I need to take other medicines after using Ohtuvayre (Ensifentrine)-Ensifentrine?

2026-02-01 22:25:32

Check Details
Ohtuvayre (Ensifentrine) - Ensifentrine is a promising adjunctive treatment option for COPD

2026-02-01 22:25:32

Check Details
Ohtuvayre (Ensifentrine) - Ensifentine is effective in key patient subgroup: boost trial

2026-02-01 22:25:32

Check Details
Fostamatinib Chinese instructions

2026-02-01 22:25:32

Check Details
Category
相关知识